Drug
Vadadustat
Vadadustat: highest development phase Phase 3, developed by Akebia Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Akebia Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vadadustat NCT06901505 | Phase 3 | Anemia of Chronic Kidney Disease |
Latest
No recent events.
Follow Vadadustat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.